Companies: 10,795·Total market cap: $144.5T
Sionna Therapeutics, Inc.

Sionna Therapeutics, Inc.

SIONNASDAQHealthcare● Active
$33.51
$-1.86(-5.26%)
Market Cap$1.5B
P/E Ratio
52W High$48.445
52W Low$13.51
Overview

Sionna Therapeutics, Inc. (SION) · Cash Flow

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · SION · as of 2026-06-10

Financial statements

Operating CF · CapEx · Free Cash Flow
Breakdown2025-122024-122023-122022-12
Operating Activities
Net Income($0.08B)($0.06B)($0.05B)($0.04B)
Depreciation & Amort.($0.00B)$0.00B$0.00B$0.00B
Stock-Based Comp.$0.01B$0.00B$0.00B$0.00B
Change in Working Capital($0.00B)($0.00B)($0.00B)$0.00B
Net Cash from Operations($0.07B)($0.05B)($0.04B)($0.04B)
Investing Activities
Capital Expenditure($0.00B)($0.00B)($0.00B)($0.00B)
Purchases of Investments($0.33B)($0.18B)($0.02B)($0.04B)
Sales of Investments$0.21B$0.06B$0.05B$0.01B
Net Cash from Investing($0.12B)($0.13B)$0.03B($0.03B)
Financing Activities
Common Stock Repurchased$0.00B$0.00B$0.00B$0.00B
Dividends Paid$0.00B$0.00B$0.00B$0.00B
Debt Issued / Repaid$0.00B$0.00B$0.00B$0.00B
Net Cash from Financing$0.21B$0.18B$0.00B$0.11B
Free Cash Flow
Free Cash Flow($0.07B)($0.05B)($0.04B)($0.04B)
FCF Margin %(computed)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B

Explore more Sionna Therapeutics, Inc. data

About Sionna Therapeutics, Inc. (SION) Cash Flow Statement

Sionna Therapeutics, Inc. generated operating cash flow of ($0.07B) and free cash flow of ($0.07B) for 2025 — a FCF margin of —. Capital expenditure was ($0.00B).

Frequently asked questions

SION · 4 questions

Sionna Therapeutics, Inc. generated free cash flow of ($0.07B) for 2025, down 26.2% year-over-year.

SION free cash flowFCF margincash flow yield

· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10